Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated from Patients with Hospital Acquired Infections in Sohag University Hospitals, Egypt
Launched by SOHAG UNIVERSITY · Oct 3, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the potential antibacterial effects of zinc oxide nanoparticles against a type of bacteria called Acinetobacter baumannii, which is often found in hospital infections, especially in intensive care units. A. baumannii can cause serious infections like pneumonia and urinary tract infections, which can lead to high rates of illness and even death among hospitalized patients. The researchers aim to see if zinc oxide nanoparticles can effectively kill this bacteria and help treat those infections.
To participate in this trial, individuals must be patients who have infections that could be caused by A. baumannii. However, those with infections from other types of bacteria or sources will not be eligible. The trial is not currently recruiting participants, so it's important to stay informed if you or a loved one might be interested in this kind of research in the future. Overall, the study hopes to find a new way to fight off these tough infections and improve patient outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients suffering from infections that can be caused by A. baumannii.
- Exclusion Criteria:
- • All patients suffering from infections that aren\'t caused by A. baumannii.
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported